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INTRODUCTION
Cancer is a major cause of death worldwide1. Cancers
are mainly due to external environmental factors such
as tobacco in the chewable and non-chewable form,
chemical ingestion, alcohol consumption, dietary factors
and viruses such as HPV (Human Papilloma virus).1
Chronic inflammation is considered as a seventh
hallmark of  cancer.1,4 Cancer cells work like normal
cells, “I do not know how to kill the cancer cells
without killing normal cells said” by a Nobel laureate
hungarian biochemist, Albert Szent-Gyorgyi.1,29
Advanced treatment modalities such as surgery,
radiotherapy, and chemotherapy fail to improve the
cancer prognosis, which is around 50% with an
increasing morbidity and mortality rate. The present
concept of holistic healing rather than healing a part
of  the body yields better results without complications.
Endorphins are endogenous morphine, more potent
than morphine acts as neuropeptides produced by the
pituitary gland through hypothalamus in response to
psychological stress, pain, sex, intense physical exercise,
yoga, meditation, acupuncture, quantum healing, music
therapy.14,16,20,21,22,25,26,29 It is also responsible for euphoria
after vigorous exercise, creating a psychological relaxed
state known as “runner’s high”.2-7,15,16,29
Endorphins are mainly of three types, -endorphins,
enkephalins and dynorphins binds to mu, delta and
kappa receptors respectively present on the immune
cells and nervous system. -endorphins are the
abundant endorphins, more potent than morphine,
synthesized and stored in the anterior pituitary gland,
it is a precursor of proopiomelanocortin (POMC)
which binds to the µ receptors and their ligands present
on the immune cells and nervous system.13,26
Neuroendocrinal pathway connects between nervous
system, endocrinal system, and immune cells in human
body. Neuroendocrinal system, which connects CNS
(central nervous system) to PNS (peripheral nervous
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system) via HPA (Hypothalamo-pituitary axis) and
ANS (Autonomic nervous system) through direct
nerve fiber connections with cells or the organs of  the
immune cells.
Chronic psychological stress is one of the predisposing
factor for cancer along with depression, frustration,
fear, hatred results in release of CRH (corticotrophic
releasing hormone) from hypothalamus activates
hypothalamo-pituitary adrenal axis (HPA-axis) through
sympathetic nervous system activity of  ANS release
neurohormones such as cortisol, ACTH, and nor-
adrenaline. These neurohormones induced
inflammatory mediators such as IL-1 , TNF-, IL-6
and COX-2 inflammatory mediators activate key
transcription factors NF-KB and STAT-3 promotes
cell proliferation, angiogenesis, immunosuppressant,
cell survival, invasion and metastasis leads to
cancer.2,3,6,7,10,11,17,19,21,22,23,29,31,32,33 Chronic inflammation
is considered as a seventh hallmark of  cancer.
Disassociation of beta-catenin from E-cadherin is an
indicator of epithelial to mesenchymal transition.30
As the process of blocking the release of
neurohormones such as cortisol, ACTH, and
noradrenalin is due to opoid receptor mediated
hyperpolarization of  neuronal cells. Increased levels
of free beta-Catenin are demonstrative of a loss of
cell adhesion.1,9,10,11,12,30.
DISCUSSION
Holistic approach of beta–endorphins in
treatment of cancer:
Endorphins are natural morphine like substances,
mainly - endorphins, which is an abundant endorphins
binds to µ receptors present on the immune cells such
as macrophages, T and B lymphocytes, monocytes,
and NK cells results in production of anti-
inflammatory cytokines such as IL-18, IL-10, IFN-.
NK cells are the natural first line of defense against
cancer and antiviral activity by producing IFN- ,
opsonin and granzyme-B.14,17,18,19,20,25,29
-endorphins produce analgesia by inhibiting substance
P, a neurotransmitter of  pain in the peripheral nervous
system through presynaptic µ (mu)-receptor binding.
-endorphins produce euphoria, rewarding and
analgesic effect by inhibiting GABA neurotransmitter
and stimulating dopamine release after binding to µ
receptors in the central nervous system.21,22,23,26,27,34
Betaendorphin inhibit chronic psychological stress by
binding of betaendorphin to the µ receptors situated
on the central nervous system results in inhibition of
GABA inhibitory neurotransmitter and produce
dopamine neurotransmitter involved in analgesic
activity, euphoria, and stress buster activity.
Betaendorphin inhibit chronic psychological stress
mediated inhibition of  HPA-axis through autonomic
nervous system (ANS) inhibits release of  stress
releasing neurohormones such as cortisol, ACTH, and
noradrenalin. These neurohormones activate
inflammatory mediators such as IL-1, TNF-, IL-6,
which further activate NF-KB and STAT-3
transcription factors involved in tumor progression.
It is also involved in suppression of sympathetic
neuronal function and the parasympathetic neuronal
stimulation by beta-endorphin neurons results in
activation of anti-inflammatory cytokines and
peripheral immunity involved in inhibition of tumor
growth and progression. Anti-inflammatory activity
by suppressing proinflammatory cytokines such as IL-
1, IL-6, and TNF-, free radicals release such as ROS
and RNS by cytokines, immune cells, which is involved
in tissue injury, cell aging, cell death, genetic mutation,
and immunesuppression. Betaendorphins also activate
anti-inflammatory cytokines such as IL-18, IL-10 and
INF-. 25,26,30,31
Beta-endorphins mediated reduced cortisol secretion
results in increases innate immune cell activity such as
NK cells and macrophages.8,13,14,15,16,17,20,21,22,23,24,25,26 It
also inhibits sympathetic neuronal excitatory activity
and activates para sympathetic nervous system activity,
improves peripheral immune activity by macrophages
and NK cells. Immune cells such as T and B
lymphocytes, monocytes, macrophages, produce beta-
endorphins. In inflammation recruitment of  immune
cells to the site of inflammation by chemokines
produce endorphins especially beta-endorphins
involved in anti-inflammatory activity by reducing
inflammatory mediators such as TNF-, IL-1, IL-6,
IL-8, and inhibiting key transcription factor NF-KB
induces cell proliferation, cellular apoptosis,
angiogenesis, chronic inflammation, invasion and
metastasis. Receptors of  opoid peptides are increases
in periphery during inflammation. (Anti-inflammatory
and analgesic effect of betaendorphin by inhibiting
the release of  substance P, a neurotransmitter of  pain
and inflammation and noradrenaline at the peripheral
nervous system, which activate inflammatory mediators
such as IL-1, TNF-, IL-6). Decrease in psychological
stress level by inhibiting HPA-axis through sympathetic
neuronal activity and activating parasympathetic
neuronal activity, decreases cortisol and nor-adrenaline
secretion, improves activity of innate immune cells such
as NK cells, macrophages, produce interferon-gamma,
opsonin, and granzyme-b involved in anti-tumor and
anti-viral activity.30,32,33
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Beta-endorphins involved in alteration of environment
of genes and gene expression in tumor microenviron-
ment. It also prolong human life span by lengthening
telomeres, which shortens with aging and anti-
inflammatory activity by neutralizing free radicals such
as ROS, RNS responsible for cell aging during
oxidative stress. Beta-endorphins suppress the release
of  ROS, RNS, free radicals and NO (nitric oxide) from
inflammatory cells and cytokines such as TNF-, IL-
8, and tumor associated macrophages, tumor
associated neutrophils, dendritic cells, involved in
genetic mutation of tumor-suppressor gene p53,
which is altered in more than 50% of all cancers,
immune suppression, cell injury and cell death.
Alteration of tumor micro-environment by
suppressing catecholamine’s induced inflammatory
cytokines (IL-1, TNF-, IL-6) and increase in anti-
inflammatory cytokines such as IL-10, IL-18. IFN-
Gamma). Beta–endorphins suppress tumor
progression by suppressing the release of
catecholamine’s such as nor-adrenaline and cortisol
mediated suppression of inflammatory mediators such
as TNF-, IL-1, COX-2, IL-6, involved in tumor
progression by activating key transcription factors NF-
KB, STAT-3, in tumor micro-environment, which
involved in cell proliferation, cell survival, angiogenesis,
genomic instability, immune suppression, invasion and
metastasis. Beta-endorphin helps in e-cadherin
expression and inhibiting the activity of proteolytic
enzymes matrix-metalloproteases -2,9 (mmp-2,9), upA
(urokinase plasminogen activator) involved in
extracellular matrix degradation, invasion and
metastasis results in cell adhesion, prevents invasion
and metastasis.30
Endorphins especially  endorphins acts as a natural
preventive, therapeutic and palliative holistic therapeutic
approach to cancer without any adverse reactions.24,28
Many in-vivo and in-vitro studies have shown that -
endorphins have antitumor activities at an early and
later stages of cancer on animal and human cancer
cells.8-10,29
Tenderness, love, care for the patient. Practice of
sympathy, empathy, compassion for caring patient
produce endorphins is the ultimate treatment of choice.
Comments: Thorough understanding of mechanism
of action of beta-endorphin, duration of action, dose
dependent action, prognosis related to stages of cancer
will be useful for future therapeutic approach to cancer.
CONCLUSION AND FUTURE PERSPECTIVE
Endorphins are endogenous opioids, Beta-endorphins
secreted by anterior pituitary gland in response to certain
stress and painful conditions of  our body. It has a
natural stress buster, analgesic, euphoric and   immune-
stimulatory activity to combat against cancer without
any adverse effects. Quantity of  secretion of  beta-
endorphins, dose dependent effects of beta-
endorphins on cancer-related to prognosis; need to
be known for future preventive, promotive,
therapeutic and palliative holistic treatment of  cancer.
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